Meet Olivier Van der Poorten

Olivier Van der Poorten holds a Ph.D. in Organic Chemistry from the Vrije Universiteit Brussel and was an FWO Postdoctoral Researcher at the Vrije Universiteit Brussel. In October 2019, he was granted with the Solvay Awards 2018 during a public ceremony to be held as part of the “Public Lectures” organized by the International Solvay Institutes of Chemistry and Physics at Flagey (Brussels). The Solvay Awards, organized by the Solvay Institutes for Physics and Chemistry, celebrates the talent and expertise of the laureates, their specialties, and distinguished academic career in chemistry or physics presenting ground-breaking research.

Olivier joined Gevers as a patent attorney trainee in 2019. His comprehensive knowledge and profound experience in synthetic organic chemistry and medicinal chemistry including various subdomains such as small organic chemicals, amino acids, peptides, and polymers, and organic chemistry techniques (solution- and solid-phase organic synthesis, multicomponent reactions, and catalysis) enable him to handle complex and diverse inventions in these fields, as well as diverse chemical patent cases in general.

He advises and represents you for the patent landscape of competitors, license contracts, freedom to operate, validity of third party’s patents, infringement situations, patentability of inventions, prosecution, opposition, and nullity actions. He handles cases in English and Dutch.

• Master of Sciences in Chemistry, Vrije Universiteit Brussel (Brussels, Belgium), 2013
• PhD of Sciences in Organic Chemistry, Vrije Universiteit Brussel (Brussels, Belgium), 2018

• PhD of Sciences in Organic Chemistry, Vrije Universiteit Brussel (Brussels, Belgium), 2018
• Patent Engineer
• Dutch Patent Attorney (2023)
• Belgian Patent Attorney (2024)
• European Patent Attorney (2024)

• Azepinone-Containing Tetrapeptide Analogues of Melanotropin Lead to Selective hMC4R Agonists and hMC5R Antagonist. ACS. Med. Chem. Lett. 2015, 6, 192-197
• Synthesis and Biological Evaluation of Compact, Conformationally Constrained Bifunctional Opioid Agonist – Neurokinin-1 Antagonist Peptidomimetics. Eur. J. Med. Chem. 2015, 92, 64-77
• T3P-Promoted, Mild, One-Pot Syntheses of Constrained Polycyclic Lactam Dipeptide Analogues via Stereoselective Pictet-Spengler and Meyers Lactamization Reactions. Org. Lett. 2015, 17, 4482-4485 Azepinone-Constrained Amino Acids in Peptide and Peptidomimetic Design. Top. Heterocycl. Chem. 2015, 1-33
• Synthesis of 3-Amino-3,4-dihydro-1H-quinolin-2-ones Through Regioselective Palladium-catalyzed Intramolecular Cyclization. Tetrahedron Lett. 2016, 57, 1547-1550
• Conformationally Constrained Peptidomimetics as Inhibitors of the Protein Arginine Methyl Transferases. Chem. Eur. J. 2016, 22, 14022-14028
• Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design. J. Med. Chem. 2016, 59, 10865-10890
• χ‑Space Screening of Dermorphin-Based Tetrapeptides Through Use of Constrained Arylazepinone and Quinolinone Scaffolds. ACS. Med. Chem. Lett. 2017, 8, 1177-1182
• Efficient One-Pot Access to Trisubstituted 2-Benzazepin-3-ones as Constrained Pseudopeptide Analogues and Privileged Scaffolds. Med. Chem. 2017, 13, 1-9
• Rapid Construction of Substituted 3-Amino-1,5-Benzothiazepin-4(5H)-One Dipeptide Scaffolds Through an Ugi-4CR – Ullmann Cross-Coupling Sequence. Org. Biomol. Chem. 2018, 16, 1242-1246
• Indoloazepinone-Constrained Oligomers as Cell-Penetrating and Blood-Brain-Barrier Permeating Compounds. ChemBioChem 2018, 19, 696-705
• Side Chain Constrained Aromatic Amino Acids for Use in Peptide Turn Mimicry and Cell-Penetrating Oligomers. Doctoral Thesis 2014-2018